自体主导多囊性病的新兴疗法
Christopher Y Chen1, Mohamad Hadla2, Ibrahim Khambati2
1PKD Foundation, Kansas City, MO, USA.
Kidney360
|December 12, 2025
概括
自体主导多囊性病 (ADPKD) 的新兴疗法超越了血管压素对抗性. 新的策略包括基因治疗,代谢干预和信号通路调制,以改善ADPKD管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 自体主导多囊性病 (ADPKD) 是导致衰竭的主要遗传性病.
- 缺陷的多素-1 (PC1) 和多素-2 (PC2) 功能会破坏细胞信号传递,代谢,并促进囊生长.
- 目前的治疗方法,如托尔瓦普坦向循环AMP (cAMP),但有局限性.
研究的目的:
- 审查目前正在临床开发中的ADPKD新兴治疗策略.
- 要突出超越血管压素对抗性的方法.
- 在ADPKD讨论精准医学的未来.
主要方法:
- 对临床试验数据和关于新型ADPKD治疗的科学文献的审查.
- 对基因导向疗法,膜信号调节器和代谢干预措施的分析.
- 探索先进技术,如人工智能和有机平台.
主要成果:
- 基因疗法 (例如,抗miR-17,药) 旨在恢复多素水平.
- 目前正在研究对角膜信号的调节 (例如,抗PAPP-A) 和新陈代谢 (例如,甲胺,SGLT2抑制剂).
- 新的cAMP降低策略 (PDE4激活) 和基因编辑显示未来的希望.
结论:
- ADPKD的治疗正在向一个分层的,以机制为导向的方法发展.
- 血管压素阻塞与代谢和基因型特定疗法的整合是关键.
- 生物标志物和人工智能的进步将使ADPKD的管理更加精确和有效.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
320
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
320
01:25Chronic Kidney Disease I: Introduction
541
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
541
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
415
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
415
01:20Acute Kidney Injury V: Interprofessional Care
277
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
277
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
243
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
243
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
163
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
163